Can We Rationalize Oral Drug Exposure Following Bariatric Surgery to Meet the Pharmacotherapeutic Needs of a Growing Patient Population? Commentary on: “Lithium Toxicity Following Roux-en-Y Gastric Bypass”.

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)81-83
Number of pages2
JournalBariatric Surgical Patient Care
Publication statusPublished - 17 Jun 2014

Cite this